MedImmune Inc., Baxter Healthcare Corp. deal

By WIR Staff | Jul 3, 1995 | 7:00 AM GMT

Baxter will commercialize MEDI's RespiGam (RSVIG) outside North America. RSVIG, a specialty immune globulin,

Read the full 144 word article

How to gain access

Continue reading with a
two-week free trial.